Avik Dutta[Author] - Search Results

Year	Number of Results
2016	1
2017	1
2018	1
2021	6
2022	2
2023	4
2024	0

1

Epigenetic regulation of T cell development.

Dutta A, Venkataganesh H, Love PE. Dutta A, et al. Int Rev Immunol. 2023;42(1):82-90. doi: 10.1080/08830185.2021.2022661. Epub 2021 Dec 30. Int Rev Immunol. 2023. PMID: 34967703 Review.

2

New insights into TCR β-selection.

Dutta A, Zhao B, Love PE. Dutta A, et al. Trends Immunol. 2021 Aug;42(8):735-750. doi: 10.1016/j.it.2021.06.005. Epub 2021 Jul 12. Trends Immunol. 2021. PMID: 34261578 Review.

3

GRB2 promotes thymocyte positive selection by facilitating THEMIS-mediated inactivation of SHP1.

Choi S, Hatzihristidis T, Gaud G, Dutta A, Lee J, Arya A, Clubb LM, Stamos DB, Markovics A, Mikecz K, Love P. Choi S, et al. Among authors: dutta a. J Exp Med. 2023 Jul 3;220(7):e20221649. doi: 10.1084/jem.20221649. Epub 2023 Apr 17. J Exp Med. 2023. PMID: 37067793 Free PMC article.

4

SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.

Yang Y, Abbas S, Sayem MA, Dutta A, Mohi G. Yang Y, et al. Among authors: dutta a. Blood Cancer J. 2023 Nov 27;13(1):171. doi: 10.1038/s41408-023-00947-y. Blood Cancer J. 2023. PMID: 38012156 Free PMC article.

5

Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.

Dutta A, Nath D, Yang Y, Le BT, Rahman MF, Faughnan P, Wang Z, Stuver M, He R, Tan W, Hutchison RE, Foulks JM, Warner SL, Zang C, Mohi G. Dutta A, et al. Leukemia. 2022 Mar;36(3):746-759. doi: 10.1038/s41375-021-01464-2. Epub 2021 Nov 5. Leukemia. 2022. PMID: 34741118 Free PMC article.

6

New Insights into Epigenetic Regulation of T Cell Differentiation.

Dutta A, Venkataganesh H, Love PE. Dutta A, et al. Cells. 2021 Dec 8;10(12):3459. doi: 10.3390/cells10123459. Cells. 2021. PMID: 34943965 Free PMC article. Review.

7

CDK6 Is a Therapeutic Target in Myelofibrosis.

Dutta A, Nath D, Yang Y, Le BT, Mohi G. Dutta A, et al. Cancer Res. 2021 Aug 15;81(16):4332-4345. doi: 10.1158/0008-5472.CAN-21-0590. Epub 2021 Jun 18. Cancer Res. 2021. PMID: 34145036 Free PMC article.

8

THEMIS increases TCR signaling in CD4⁺CD8⁺ thymocytes by inhibiting the activity of the tyrosine phosphatase SHP1.

Choi S, Lee J, Hatzihristidis T, Gaud G, Dutta A, Arya A, Clubb LM, Stamos DB, Markovics A, Mikecz K, Love PE. Choi S, et al. Among authors: dutta a. Sci Signal. 2023 May 9;16(784):eade1274. doi: 10.1126/scisignal.ade1274. Epub 2023 May 9. Sci Signal. 2023. PMID: 37159521 Free PMC article.

9

Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.

Rahman MF, Yang Y, Le BT, Dutta A, Posyniak J, Faughnan P, Sayem MA, Aguilera NS, Mohi G. Rahman MF, et al. Among authors: dutta a. Nat Commun. 2022 Sep 13;13(1):5347. doi: 10.1038/s41467-022-32928-3. Nat Commun. 2022. PMID: 36100596 Free PMC article.

10

U2af1 is required for survival and function of hematopoietic stem/progenitor cells.

Dutta A, Yang Y, Le BT, Zhang Y, Abdel-Wahab O, Zang C, Mohi G. Dutta A, et al. Leukemia. 2021 Aug;35(8):2382-2398. doi: 10.1038/s41375-020-01116-x. Epub 2021 Jan 7. Leukemia. 2021. PMID: 33414485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year